Cost-efficacy analysis of hormonal treatments for advanced prostate cancer

Introduction: prostatic cancer is the second more frequent cancer in Italy (after lung cancer) and is the third cancer-related death cause. Age is the principal risk factor and, given the ageing process undergoing in the Italian population, it seems clear that the public sanitary expenditure to trea...

Full description

Bibliographic Details
Main Authors: Sergio Iannazzo, Lorenzo Pradelli
Format: Article
Language:English
Published: SEEd Medical Publishers 2008-09-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/226